Serinus Biosciences
YC S22 · Active · Combinations therapy by rational design
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
 AlixiaShared: cancer treatment, oncology, therapeuticsActiveOther | Other | Active | YCW22 |
 Notable LabsShared: cancer cell, cancer treatment, oncologyPublicOther | Other | Public | YCW15 |
 Guardian BioShared: oncology, therapeutics, biotechActiveOther | Other | Active | YCS22 |
 Felix BiotechnologyShared: therapeutics, biotech, resistanceInactiveOther | Other | Inactive | YCW20 |
 Eris BiotechShared: oncology, therapeutics, biotechActiveOther | Other | Active | YCW24 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
 Velorum TherapeuticsShared: oncology, therapeutics, biotechActiveOther | Other | Active | YCW24 |
 SynsoryBioShared: oncology, therapeutics, biotechActiveOther | Other | Active | YCW24 |
 Modulari-TShared: cancer cell, oncology, biotechActiveOther | Other | Active | YCW23 |
 Kopra BioShared: oncology, therapeutics, biotechActiveOther | Other | Active | YCS24 |
 Granza BioShared: oncology, therapeutics, biotechActiveOther | Other | Active | YCW24 |
Also from S22 in AI
All of S22
About Serinus Biosciences
Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, our AI engine uncovers how cancer cells evolve treatment resistance and identifies molecules to overcome resistance escape routes. We design combinations that are safer, more effective, and can get to patients quickly. Founded by MIT PhDs and supported by a scientific advisory board of top academics from the Broad Institute, Dana-Farber, and UCSD, Serinus is powered by Y Combinator and other top investors to revolutionize precision medicine.
- YC batch
- S22 · Summer 2022
- Status, per YC
- Active
- Category
- AI
- Team size
- 6
- Location
- New York City, NY, USA; New York, NY, USA
- Checked
- 35m ago
YC tags: Biotech, Therapeutics, Oncology
Serinus Biosciences: questions
Which YC batch was Serinus Biosciences in?
Serinus Biosciences was in Y Combinator's Summer 2022 batch (S22).
Is Serinus Biosciences still active?
Y Combinator lists Serinus Biosciences as active.
Where is Serinus Biosciences based?
Serinus Biosciences lists New York City, NY, USA; New York, NY, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.